User profiles for Anat Fisher
 | Anat FisherResearch Associate, University of British Columbia Verified email at ubc.ca Cited by 607 |
Sodium–glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
…, N Hu, S Alessi-Severini, A Fisher… - Annals of internal …, 2020 - acpjournals.org
Background: Sodium–glucose cotransporter-2 (SGLT-2) inhibitors could increase the risk
for diabetic ketoacidosis (DKA). Objective: To assess whether SGLT-2 inhibitors, compared …
for diabetic ketoacidosis (DKA). Objective: To assess whether SGLT-2 inhibitors, compared …
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Objective To compare the risk of cardiovascular events between sodium glucose cotransporter
2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among people with …
2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among people with …
Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics: a National Institute of Allergy and Infectious …
The development of biologics targeting various aspects of type 2 inflammation for the treatment
of chronic rhinosinusitis with nasal polyps (CRSwNP) will provide clinicians with powerful …
of chronic rhinosinusitis with nasal polyps (CRSwNP) will provide clinicians with powerful …
Comparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
CR Dormuth, B Winquist, A Fisher, F Wu… - JAMA Network …, 2021 - jamanetwork.com
Importance Ondansetron is frequently used to treat nausea and vomiting during pregnancy.
Although some studies reported important safety signals, few studies have been sufficiently …
Although some studies reported important safety signals, few studies have been sufficiently …
Sodium–glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
OBJECTIVE Reports of amputations associated with sodium–glucose cotransporter 2 (SGLT2)
inhibitors have been inconsistent. We aimed to compare the risk of below-knee …
inhibitors have been inconsistent. We aimed to compare the risk of below-knee …
Nirmatrelvir-ritonavir and COVID-19 mortality and hospitalization among patients with vulnerability to COVID-19 complications
CR Dormuth, JD Kim, A Fisher, J Piszczek… - JAMA Network …, 2023 - jamanetwork.com
Importance Postmarket analysis of individuals who receive nirmatrelvir and ritonavir (Paxlovid
[Pfizer]) is essential because they differ substantially from individuals included in …
[Pfizer]) is essential because they differ substantially from individuals included in …
[HTML][HTML] Comparative persistence of the TNF antagonists in rheumatoid arthritis–a population-based cohort study
Objective To compare persistence with tumor necrosis factor alpha (TNF) antagonists
among rheumatoid arthritis patients in British Columbia. Treatment persistence has been …
among rheumatoid arthritis patients in British Columbia. Treatment persistence has been …
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational …
Background: Direct oral anticoagulants (DOACs) have widely replaced warfarin for stroke
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
[HTML][HTML] Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Objectives The United States Food & Drug Administration released an advisory in 2016 that
fluoroquinolones be relegated to second-line agents for uncomplicated urinary tract …
fluoroquinolones be relegated to second-line agents for uncomplicated urinary tract …
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study
A Fisher, M Fralick, KB Filion… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aim To compare urosepsis rates in patients with type 2 diabetes treated using sodium‐glucose
co‐transporter‐2 inhibitors (SGLT2i) with dipeptidyl peptidase‐4 inhibitors (DPP4i) in a …
co‐transporter‐2 inhibitors (SGLT2i) with dipeptidyl peptidase‐4 inhibitors (DPP4i) in a …